Cellectar Biosciences Statistics

Total Valuation

CLRB has a market cap or net worth of $64.10 million. The enterprise value is $45.34 million.

Market Cap	64.10M
Enterprise Value	45.34M

Important Dates

The last earnings date was Monday, November 18, 2024, before market open.

Earnings Date	Nov 18, 2024
Ex-Dividend Date	n/a

Share Statistics

CLRB has 40.57 million shares outstanding. The number of shares has increased by 173.55% in one year.

Current Share Class	35.85M
Shares Outstanding	40.57M
Shares Change (YoY)	+173.55%
Shares Change (QoQ)	+6.27%
Owned by Insiders (%)	2.83%
Owned by Institutions (%)	13.13%
Float	25.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	41.37
P/TBV Ratio	41.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.03.

Current Ratio	1.77
Quick Ratio	1.69
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -474.63% and return on invested capital (ROIC) is -290.49%.

Return on Equity (ROE)	-474.63%
Return on Assets (ROA)	-109.57%
Return on Capital (ROIC)	-290.49%
Revenue Per Employee	n/a
Profits Per Employee	-$2.51M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-60,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.17% in the last 52 weeks. The beta is 1.01, so CLRB's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-26.17%
50-Day Moving Average	2.03
200-Day Moving Average	2.73
Relative Strength Index (RSI)	21.39
Average Volume (20 Days)	517,523

Short Selling Information

The latest short interest is 1.84 million, so 4.52% of the outstanding shares have been sold short.

Short Interest	1.84M
Short Previous Month	1.96M
Short % of Shares Out	4.52%
Short % of Float	7.31%
Short Ratio (days to cover)	8.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-51.58M
Pretax Income	-51.04M
Net Income	-50.11M
EBITDA	-51.31M
EBIT	-51.58M
Earnings Per Share (EPS)	-$1.92

Full Income Statement

Balance Sheet

The company has $34.26 million in cash and $512,750 in debt, giving a net cash position of $33.75 million or $0.83 per share.

Cash & Cash Equivalents	34.26M
Total Debt	512,750
Net Cash	33.75M
Net Cash Per Share	$0.83
Equity (Book Value)	16.55M
Book Value Per Share	0.04
Working Capital	15.58M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-173.55%
Shareholder Yield	-173.55%
Earnings Yield	-78.18%
FCF Yield	n/a

Analyst Forecast

The average price target for CLRB is $20.00, which is 1,165.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	1,165.82%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 22, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1